HOME >> BIOLOGY >> NEWS
May: Multiple Sclerosis Awareness Month -- latest research is good news

Montreal, QC -- May is Multiple Sclerosis Month and there is no better way of raising awareness for this unpredictable and often debilitating disease then by highlighting the latest research that might offer hope for the 55 to 75, 000 sufferers across Canada. A new drug under investigation for Multiple Sclerosis (MS) appears to be safe and effective according to studies involving researchers at the Montreal Neurological Institute. The studies, presented this week at the American Academy of Neurologys (AAN) 59th Annual Meeting in Boston, also provide deeper insight into the biology of this complex disease. Canadians have one of the highest rates of Multiple Sclerosis (MS) in the world with approximately 1,000 new cases of MS diagnosed each year. MS is the most common neurological disease affecting young adults in Canada and affects 18% of all Quebecers.

The Phase I and Phase II studies involved people in Canada and the USA with relapsing-remitting MS, in which symptoms flare up and then subside. Treatment with the drug rituximab significantly reduced the number of new brain lesions and the frequency of relapses, times when symptoms of MS flare up.

Rituximab is a therapeutic antibody that selectively targets and depletes a set of immune cells called B-cells by binding to a specific protein on their surface.

"This is the first drug to selectively target B-cells in MS and the significance of its effectiveness is two-fold," says Dr. Amit Bar-Or, neurologist at the Montreal Neurological Institute (MNI) at McGill University, Montreal, Canada and lead investigator in the Phase I study. "Not only might it present a significantly improved therapy for patients with relapsing-remitting MS, but it provides a clearer picture of the role that B-cells play in the disease. Its a particularly exciting time and we think meaningful to advancing treatment options for patients."

The Phase I trial was primarily designed to assess the safety
'"/>

Contact: Anita Kar
anita.kar@mcgill.ca
514-398-3376
Montreal Neurological Institute and Hospital
2-May-2007


Page: 1 2

Related biology news :

1. Alleviating the burden of Multiple Sclerosis
2. Multiple sclerosis progression linked to immune-cell substance
3. Multiple genes permit closely related fish species to mix and match their color vision
4. Multiple genetic flavors may explain autism
5. Multiple sightings of long-lost woodpecker reported
6. Multiple-drug resistant gene expression pattern predicts treatment outcome for pediatric leukemia
7. Brain Awareness Week teaches kids how their brains work
8. Breast Cancer Month story tips from Georgetown University Medical Center
9. National Academies advisory: Feb. 15 program for African-American History Month
10. AAAS decries latest stem cell veto
11. Brain, size and gender surprises in latest fossil tying humans, apes and monkeys

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/19/2020)... ... 18, 2020 , ... Join experts from Envigo Lauren Klaskala, Project ... live webinar on Wednesday, July 8, 2020 at 11am EDT (4pm BST/UK). , ... new models. However, while modifying the genome may be more straightforward, the challenge to ...
(Date:6/11/2020)... Fla. (PRWEB) , ... June 08, 2020 , ... ... demand for masks and other protective measures to protect workers in the medical ... and their dedicated staffs who valiantly risk their lives every day to provide ...
(Date:6/5/2020)... ... , ... Murrieta Genomics has announced that its wholly owned subsidiary, ... for Next Generation Genomic Sequencing (NGS) . This is the third application filed ... preparation. , “I have been at the bench for over 20 years,” stated Brandon ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... (PRWEB) , ... July 29, 2020 , ... R3 Stem ... injections for only $3950. With 50 million stem cells total, patients may choose which ... cell therapy works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical ...
(Date:7/31/2020)... ... July 29, 2020 , ... ... transmitter systems that can be configured to drive Klystrons, TWTs, IOTs, and magnetrons. ... drive one or two switches in a push-pull configuration; yielding fast fall time ...
(Date:7/31/2020)... SOMERSET, N.J (PRWEB) , ... July 29, 2020 ... ... editing company, and Catalent, the leading global provider of advanced delivery technologies, development, ... products, today announced that they have entered into a strategic partnership whereby Catalent ...
(Date:7/31/2020)... ... July 29, 2020 , ... The ... centers in 16 countries, has reached its 20th anniversary of worldwide use. Introduced ... use at top universities including University of Pennsylvania, University of Michigan, University of ...
Breaking Biology Technology:
Cached News: